Ethyl pyruvate diminishes the endotoxin-induced inflammatory response of bovine mammary endothelial cells

Journal of Dairy Science

Volumn 93, Issue 11, 2010, Pages 5188-5199

  Corl, C M ^a   Robinson, H R ^a   Contreras, G A ^a   Holcombe, S J ^a   Cook, V L ^a   Sordillo, L M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Coliform mastitis; Endothelium; Ethyl pyruvate; Inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; ENDOTOXIN; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER;

ANIMAL; ARTICLE; BOVINE MASTITIS; CATTLE; CELL CULTURE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; METABOLISM; UDDER;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CATTLE; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTOXINS; FEMALE; INFLAMMATION MEDIATORS; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE; PYRUVATES;

BOVINAE;

EID: 78649341883     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2010-3250     Document Type: Article

References (42)

1. Aherne K.M., Davis M.R., Sordillo L.M. Isolation and characterization of bovine mammary endothelial cells. Methods Cell Sci. 1995, 17:41-46.
2. Anderson K.L., Kindahl H., Petroni A., Smith A.R., Gustafsson B.K. Arachidonic acid metabolites in milk of cows during acute coliform mastitis. Am. J. Vet. Res. 1985, 46:1573-1577.
3. Bannerman D.D. Pathogen-dependent induction of cytokines and other soluble inflammatory mediators during intramammary infection of dairy cows. J. Anim. Sci. 2009, 87(Suppl):10-25.
4. Bannerman D.D., Goldblum S.E. Direct effects of endotoxin on the endothelium: barrier function and injury. Lab. Invest. 1999, 79:1181-1199.
5. Bannerman D.D., Goldblum S.E. Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 284:L899-L914.
6. Barton B.E., Jackson J.V. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect. Immun. 1993, 61:1496-1499.
7. Bennett-Guerrero E., Swaminathan M., Grigore A.M., Roach G.W., Aberle L.G., Johnston J.M., Fink M.P. A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass. J. Cardiothorac. Vasc. Anesth. 2009, 23:324-329.
8. Braquet P., Hosford D., Braquet M., Bourgain R., Bussolino F. Role of cytokines and platelet-activating factor in microvascular immune injury. Int. Arch. Allergy Appl. Immunol. 1989, 88:88-100.
9. Cao Y.Z., Reddy C.C., Sordillo L.M. Altered eicosanoid biosynthesis in selenium-deficient endothelial cells. Free Radic. Biol. Med. 2000, 28:381-389.
10. Corl C.M., Gandy J.C., Sordillo L.M. Platelet activating factor production and proinflammatory gene expression in endotoxin-challenged bovine mammary endothelial cells. J. Dairy Sci. 2008, 91:3067-3078.
11. Dauphinee S.M., Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab. Invest. 2006, 86:9-22.
12. FAO/WHO. 2001. Food and Agriculture Organization of the United Nations and the World Health Organization: Summary of Evaluations performed by the Joint FAO/WHO expert committee on food additives. Accessed February 2, 2010. http://jecfa.ilsi.org/.
13. Fink M.P. Ethyl pyruvate: A novel anti-inflammatory agent. J. Intern. Med. 2007, 261:349-362.
14. Grandel U., Grimminger F. Endothelial responses to bacterial toxins in sepsis. Crit. Rev. Immunol. 2003, 23:267-299.
15. Harlan J.M., Harker L.A., Reidy M.A., Gajdusek C.M., Schwartz S.M., Striker G.E. Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab. Invest. 1983, 48:269-274.
16. Harlan J.M., Harker L.A., Striker G.E., Weaver L.J. Effects of lipopolysaccharide on human endothelial cells in culture. Thromb. Res. 1983, 29:15-26.
17. Hauser B., Kick J., Asfar P., Ehrmann U., Albicini M., Vogt J., Wachter U., Bruckner U.B., Fink M.P., Radermacher P., Bracht H. Ethyl pyruvate improves systemic and hepatosplanchnic hemodynamics and prevents lipid peroxidation in a porcine model of resuscitated hyperdynamic endotoxemia. Crit. Care Med. 2005, 33:2034-2042.
18. Hill A.W., Frost A.J., Brooker B.E. Progressive pathology of severe Escherichia coli mastitis in dairy cows. Res. Vet. Sci. 1984, 37:179-187.
19. Hogan J., Smith K.L. Coliform mastitis. Vet. Res. 2003, 34:507-519.
20. Johansson A.S., Johansson-Haque K., Okret S., Palmblad J. Ethyl pyruvate modulates acute inflammatory reactions in human endothelial cells in relation to the NF-kappaB pathway. Br. J. Pharmacol. 2008, 154:1318-1326.
21. Jones S.A., Horiuchi S., Topley N., Yamamoto N., Fuller G.M. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 2001, 15:43-58.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
23. Lohuis J.A., Schukken Y.H., Verheijden J.H., Brand A., Van Miert A.S. Effect of severity of systemic signs during the acute phase of experimentally induced Escherichia coli mastitis on milk production losses. J. Dairy Sci. 1990, 73:333-341.
24. Olson N.C., Hellyer P.W., Dodam J.R. Mediators and vascular effects in response to endotoxin. Br. Vet. J. 1995, 151:489-522.
25. Peter A.T., Clark P.W., Van Roekel D.E., Luker C.W., Gaines J.D., Bosu W.T. Temporal changes in metabolites of prostanoids in milk of heifers after intramammary infusion of Escherichia coli organisms. Prostaglandins 1990, 39:451-457.
26. Rainard P., Riollet C. Innate immunity of the bovine mammary gland. Vet. Res. 2006, 37:369-400.
27. Reade M.C., Fink M.P. Bench-to-bedside review: Amelioration of acute renal impairment using ethyl pyruvate. Crit. Care 2005, 9:556-560.
28. Riollet C., Rainard P., Poutrel B. Differential induction of complement fragment C5a and inflammatory cytokines during intramammary infections with Escherichia coli and Staphylococcus aureus. Clin. Diagn. Lab. Immunol. 2000, 7:161-167.
29. Sappington P.L., Han X., Yang R., Delude R.L., Fink M.P. Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated Caco-2 enterocytic monolayers. J. Pharmacol. Exp. Ther. 2003, 304:464-476.
30. Shuster D.E., Lee E.K., Kehrli M.E. Bacterial growth, inflammatory cytokine production, and neutrophil recruitment during coliform mastitis in cows within ten days after calving, compared with cows at midlactation. Am. J. Vet. Res. 1996, 57:1569-1575.
31. Smith K.L., Harrison J.H., Hancock D.D., Todhunter D.A., Conrad H.R. Effect of vitamin E and selenium supplementation on incidence of clinical mastitis and duration of clinical symptoms. J. Dairy Sci. 1984, 67:1293-1300.
32. Song M., Kellum J.A. Interleukin-6. Crit. Care Med. 2005, 33(Suppl):S463-S465.
33. Song M., Kellum J.A., Kaldas H., Fink M.P. Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells. J. Pharmacol. Exp. Ther. 2004, 308:307-316.
34. Sordillo L.M., Peel J.E. Effect of interferon-gamma on the production of tumor necrosis factor during acute Escherichia coli mastitis. J. Dairy Sci. 1992, 75:2119-2125.
35. Sordillo L.M., Streicher K.L., Mullarky I.K., Gandy J.C., Trigona W., Corl C.M. Selenium inhibits 15-hydroperoxyoctadecadienoic acid-induced intracellular adhesion molecule expression in aortic endothelial cells. Free Radic. Biol. Med. 2008, 44:34-43.
36. Sordillo L.M., Weaver J.A., Cao Y.Z., Corl C., Sylte M.J., Mullarky I.K. Enhanced 15-HPETE production during oxidant stress induces apoptosis of endothelial cells. Prostaglandins Other Lipid Mediat. 2005, 76:19-34.
37. Steibel J.P., Poletto R., Coussens P.M., Rosa G.J. A powerful and flexible linear mixed model framework for the analysis of relative quantification RT-PCR data. Genomics 2009, 94:146-152.
38. Tak P.P., Firestein G.S. NF-kappaB: A key role in inflammatory diseases. J. Clin. Invest. 2001, 107:7-11.
39. Ulloa L., Ochani M., Yang H., Tanovic M., Halperin D., Yang R., Czura C.J., Fink M.P., Tracey K.J. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl. Acad. Sci. USA 2002, 99:12351-12356.
40. Vangroenweghe F., Duchateau L., Boutet P., Lekeux P., Rainard P., Paape M.J., Burvenich C. Effect of carprofen treatment following experimentally induced Escherichia coli mastitis in primiparous cows. J. Dairy Sci. 2005, 88:2361-2376.
41. Venkataraman R., Kellum J.A., Song M., Fink M.P. Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock. Shock 2002, 18:507-512.
42. Yang R., Gallo D.J., Baust J.J., Uchiyama T., Watkins S.K., Delude R.L., Fink M.P. Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 283:G212-G221.